09.09.2014 Views

Autism Studies and Related Medical Conditions, January 2009 - TACA

Autism Studies and Related Medical Conditions, January 2009 - TACA

Autism Studies and Related Medical Conditions, January 2009 - TACA

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

homocarnosine interaction, with possible anticonvulsive effects. We investigated<br />

31 children with autistic spectrum disorders in an 8-week, double-blinded study<br />

to determine if 800 mg L-carnosine daily would result in observable changes<br />

versus placebo. Outcome measures were the Childhood <strong>Autism</strong> Rating Scale, the<br />

Gilliam <strong>Autism</strong> Rating Scale, the Expressive <strong>and</strong> Receptive One-Word Picture<br />

Vocabulary tests, <strong>and</strong> Clinical Global Impressions of Change. Children on placebo<br />

did not show statistically significant changes. After 8 weeks on L-carnosine,<br />

children showed statistically significant improvements on the Gilliam <strong>Autism</strong><br />

Rating Scale (total score <strong>and</strong> the Behavior, Socialization, <strong>and</strong> Communication<br />

subscales) <strong>and</strong> the Receptive One-Word Picture Vocabulary test (all P < .05).<br />

Improved trends were noted on other outcome measures. Although the<br />

mechanism of action of L-carnosine is not well understood, it may enhance<br />

neurologic function, perhaps in the enterorhinal or temporal cortex.<br />

PMID: 12585724 [PubMed - indexed for MEDLINE]<br />

Chugani DC, Sundram BS, Behen M, Lee ML, Moore GJ. Evidence of altered energy<br />

metabolism in autistic children. Prog Neuropsychopharmacol Biol Psychiatry. 1999<br />

May;23(4):635-41.<br />

Department of Pediatrics, Wayne State University School of Medicine, Children's<br />

Hospital of Michigan, Detroit, USA. dchugani@pet.wayne.edu<br />

1. In this pilot study, the authors investigated the hypotheses there are<br />

increased concentrations of lactate in brain <strong>and</strong> plasma <strong>and</strong> reduced brain<br />

concentrations of N-acetyl-aspartate (NAA) in autistic children. 2. NAA <strong>and</strong><br />

lactate levels in the frontal lobe, temporal lobe <strong>and</strong> the cerebellum of 9 autistic<br />

children were compared to 5 sibling controls using MRS. Plasma lactate levels<br />

were measured in 15 autistic children compared to 15 children with epilepsy. 3.<br />

Preliminary results show lower levels of NAA cerebellum in autistic children (p =<br />

0.043). Lactate was detected in the frontal lobe in one autistic boy, but was not<br />

detected any of the other autistic subjects or siblings. 4. Plasma lactate levels<br />

were higher in the 15 autistic children compared to 15 children with epilepsy (p<br />

= 0.0003). 5. Higher plasma lactate in the autistic group is consistent with<br />

metabolic changes in some autistic children. The findings of altered brain NAA<br />

<strong>and</strong> lactate in autistic children suggest that MRS may be useful characterizing<br />

regional neurochemical <strong>and</strong> metabolic abnormalities in autistic children.<br />

PMID: 10390722 [PubMed - indexed for MEDLINE]<br />

<strong>Autism</strong> <strong>Studies</strong> & <strong>Related</strong> <strong>Medical</strong> <strong>Conditions</strong> – <strong>TACA</strong> © Page 188

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!